Updated:
LG Chem
LG Chem spun out of LG Corporation in 1947 as a chemicals manufacturer making cosmetics containers and combs. Chairman Koo Kwang-mo inherited control through...
LG Chem
LG Chem spun out of LG Corporation in 1947 as a chemicals manufacturer making cosmetics containers and combs. Chairman Koo Kwang-mo inherited control through the family holding structure that dominates South Korea's chaebol economy. The company today operates four separate business units: petrochemicals, advanced materials, energy solutions, and life sciences—a structure that routes cash from its legacy naphtha-cracking complex in Yeosu into its North American battery factories. The firm's investment strategy is direct industrial deployment, not financial-portfolio allocation. In energy solutions, LG Chem has committed over $3 billion to build a cathode plant in Montgomery County, Tennessee, complementing its joint venture with General Motors in Ultium Cells LLC, which operates three US battery gigafactories. The advanced-materials unit supplies high-nickel cathodes to Tesla and Hyundai Motor Group. LG Chem also maintains a pharmaceutical pipeline through its life sciences division, which focuses on novel drug development and diagnostic reagents—originating from its 2002 acquisition of LG Life Sciences (per the firm's official communications). Its geographic footprint spans South Korea, Poland (a Wroclaw EV battery plant), China, and the United States. Shin Hak-cheol has served as Vice Chairman and CEO since 2019, overseeing roughly $40 billion in annual revenue. The company's workforce exceeds 14,000 globally, with manufacturing floors in Cheongju, Yeosu, Tennessee, and Wroclaw. Adjacent corporate structures include stakeholdings in LG Energy Solution, which was carved out via an IPO in 2022—the largest in South Korean history at the time. In September 2023, LG Chem broke ground on its Tennessee cathode plant, a project designed to qualify for Inflation Reduction Act tax credits and bypass Chinese supply-chain dependencies (per Reuters, September 2023). LG Chem's structural differentiator is the petrochemical-to-battery pivot—no Western company has converted old-economy chemical cash flow into new-economy electrification capacity at equivalent speed. The firm operates as a principal investor building heavy industrial assets, not a fund manager. Its governance sits inside the LG Group cross-shareholding network, meaning strategic decisions route through the Koo family office in a way that combines corporate discipline with familial control.
General information
Firm type
Corporate Investor
Year founded
1947
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
128 Yeoui-daero, Yeongdeungpo-gu, Seoul, South Korea
Additional offices
Montgomery County, TN, USA · Wroclaw, Poland · Cheongju, South Korea · Yeosu, South Korea
Principals
Shin Hak-cheol
Vice Chairman & CEO
Koo Kwang-mo
Chairman of LG Corp
Sector focus
Frequently asked questions
Who controls investment decisions at LG Chem?
Vice Chairman and CEO Shin Hak-cheol leads operational and capital deployment decisions, reporting to LG Corp Chairman Koo Kwang-mo. The Koo family holds ultimate control through LG Corporation's 33.3% stake. Major investments, such as the Tennessee cathode plant, require board approval and often involve coordination with affiliated entities like LG Energy Solution.
How does LG Chem source its investment opportunities?
LG Chem sources opportunities through industrial logic rather than financial screening. Its EV battery plants originate from long-term supply agreements with automakers like General Motors and Hyundai, which guarantee off-take. The firm builds capacity in response to contracted demand—its Tennessee plant, for instance, was predicated on Inflation Reduction Act eligibility and US automaker commitments.
Is LG Chem a corporate venture capital arm or an operating company?
LG Chem is an operating company that deploys capital directly into its own industrial assets. It does not operate a standalone venture capital unit for external startup investments. When it participates in joint ventures like Ultium Cells LLC with General Motors, it acts as a co-owner and industrial partner rather than a financial investor.
What investment stages does LG Chem target in its life sciences division?
The life sciences division focuses on clinical-stage novel drug development, specializing in metabolic diseases like diabetes and obesity, autoimmune conditions, and oncology. LG Chem also manufactures diagnostic reagents and has a veterinary medicine portfolio. The division prefers internal R&D over acquiring late-stage assets.
Where does LG Chem's underlying capital come from?
LG Chem generates capital organically through its petrochemicals and advanced materials operations, which produce steady free cash flow. The company is part of the LG Group conglomerate, whose founding wealth traces back to Koo In-hwoi's establishment of Lak Hui Chemical in 1947. The Koo family controls the group through a circular shareholding structure typical of Korean chaebols.
How is LG Chem related to LG Energy Solution?
LG Chem was the sole owner of LG Energy Solution until its carve-out IPO on the Korea Exchange in January 2022—the largest IPO in South Korean history. LG Chem remains the majority shareholder and consolidates the entity financially. The two firms operate separately, with LG Energy Solution managing the cell-manufacturing business while LG Chem retains control of cathode and advanced-materials production.
Does LG Chem maintain philanthropic structures, and how are they separated?
LG Chem falls under the broader LG Group's social contribution framework, which includes the LG Evergreen Foundation, the LG India CSR Foundation, and the LG Yonam Foundation. These entities are funded by LG Corp and its affiliates and focus on education, environmental sustainability, and community development. They operate independently of the industrial investment function.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: